Analytics Capabilities Updates
-
Recipharm Advanced Bio Capacity Update July 2025: Analytical Services
7/28/2025
ReciBioPharm’s specialized CDMO capabilities include development and manufacture for new biological modalities. Discover the benefits of choosing a CDMO with complete end-to-end services and in-house analytical capabilities.
-
Reducing CMC Risk With Proven Analytical And Formulation Expertise
7/28/2025
Explore real examples of how this outsourcing partner helps drug sponsors through transparency that empowers, integration that simplifies, methods that de-risk, and experience that accelerates.
-
Contract GMP Biologics Analytical Services
7/28/2025
Pedro Morales, Director, Scientific Advisor of Biologics Analytical Services, explores how Catalent delivers tailored solutions through deep expertise and advanced capabilities.
-
Alcami Capacity Update July 2025: Analytical Services
7/28/2025
Alcami’s laboratory services can support many drug substance or drug product modalities, all product phases, and specialty laboratory services, including in-house microbiology, raw materials, and analytical development.